The anti-GD2 therapy naxitamab has been included in the NCCN Clinical Practice Guidelines in Oncology for the treatment of ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

The National Comprehensive Cancer Network (NCCN) policy summit highlighted the need for improved communication between ...

Q1 2025 Earnings Call Transcript May 7, 2025 Geron Corporation beats earnings expectations. Reported EPS is $-0.03, ...

The panelists began by explaining why close coordination is so important.

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Good day, everyone, and welcome to the Syndax First Quarter 2025 ...

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...